Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Bezin

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
BMJ Open|December 16, 2025
Effectiveness of antihypertensive drugs for secondary prevention of ischaemic stroke: a nationwide historic cohort studyJulia Perrier, Amelie Gabet, Valérie Olié, et al.
Pharmacoepidemiology and Drug Safety|July 3, 2022
Potentially inappropriate medication use by level of polypharmacy among US Veterans 49-64 and 65-70 years oldJordan Guillot, Christopher T Rentsch, Kirsha S Gordon, et al.
Journal of Clinical Medicine|November 25, 2020
The Burden of Potentially Inappropriate Medications in Chronic PolypharmacyJordan Guillot, Sandy Maumus-Robert, Alexandre Marceron, et al.
BMJ (Clinical Research Ed.)|March 24, 2022
Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control studyAnne Bénard-Laribière, Emilie Hucteau, Stéphanie Debette, et al.
Fundamental & Clinical Pharmacology|February 23, 2026
SGLT-2 Inhibitors Use in Hospitalized Patients in France: A Cross-Sectional StudyMaxime Demourgues, Julien Bezin, Romain Griffier, et al.
Pharmacoepidemiology and Drug Safety|May 26, 2017
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiologyJulien Bezin, Mai Duong, Régis Lassalle, et al.
British Journal of Cancer|September 7, 2016
Persistence to 5-year hormonal breast cancer therapy: a French national population-based studyPauline Bosco-Lévy, Jeremy Jové, Philip Robinson, et al.
Diabetes, Obesity & Metabolism|January 30, 2024
Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance databaseSibylle de Germay, Elodie Pambrun, Antoine Pariente, et al.
Thorax|October 11, 2024
Association of fluoroquinolones with the risk of spontaneous pneumothorax: nationwide case-time-control studyAnne Bénard-Laribière, Elodie Pambrun, Serge Kouzan, et al.
Drug Safety|November 30, 2017
An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot StudyMickael Arnaud, Bernard Bégaud, Frantz Thiessard, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
BMJ Open|December 16, 2025
Effectiveness of antihypertensive drugs for secondary prevention of ischaemic stroke: a nationwide historic cohort studyJulia Perrier, Amelie Gabet, Valérie Olié, et al.
Pharmacoepidemiology and Drug Safety|July 3, 2022
Potentially inappropriate medication use by level of polypharmacy among US Veterans 49-64 and 65-70 years oldJordan Guillot, Christopher T Rentsch, Kirsha S Gordon, et al.
Journal of Clinical Medicine|November 25, 2020
The Burden of Potentially Inappropriate Medications in Chronic PolypharmacyJordan Guillot, Sandy Maumus-Robert, Alexandre Marceron, et al.
BMJ (Clinical Research Ed.)|March 24, 2022
Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control studyAnne Bénard-Laribière, Emilie Hucteau, Stéphanie Debette, et al.
Fundamental & Clinical Pharmacology|February 23, 2026
SGLT-2 Inhibitors Use in Hospitalized Patients in France: A Cross-Sectional StudyMaxime Demourgues, Julien Bezin, Romain Griffier, et al.
Pharmacoepidemiology and Drug Safety|May 26, 2017
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiologyJulien Bezin, Mai Duong, Régis Lassalle, et al.
British Journal of Cancer|September 7, 2016
Persistence to 5-year hormonal breast cancer therapy: a French national population-based studyPauline Bosco-Lévy, Jeremy Jové, Philip Robinson, et al.
Diabetes, Obesity & Metabolism|January 30, 2024
Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance databaseSibylle de Germay, Elodie Pambrun, Antoine Pariente, et al.
Thorax|October 11, 2024
Association of fluoroquinolones with the risk of spontaneous pneumothorax: nationwide case-time-control studyAnne Bénard-Laribière, Elodie Pambrun, Serge Kouzan, et al.
Drug Safety|November 30, 2017
An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot StudyMickael Arnaud, Bernard Bégaud, Frantz Thiessard, et al.
Pageof 8